Target intelligence / Profile preview

Aconitase 2 pseudogene 2 (ACO2P2)

Target
ACO2P2
Molecular classification
Other (Pseudogene)
01

Overview

ACO2P2 is a pseudogene related to the ACO2 (aconitase 2, mitochondrial) gene, which encodes the enzyme aconitase 2 that is critical for the TCA (tricarboxylic acid) cycle in mitochondria[1][3][4]. Pseudogenes such as ACO2P2 do not usually produce functional proteins. They arise from duplication or retrotransposition events and typically lack biological activity or direct therapeutic relevance. There is no documentation that ACO2P2 encodes an active enzyme, serves as a drug target, or has disease associations, though some pseudogenes can act as non-coding RNA regulators[1][3][4]. **Clarification:** - There is nothing inherently "incorrect" about the existence of this pseudogene, but it should not be listed as a therapeutic target or functional protein-coding gene. If the intent is to find a true target, the canonical enzyme is "Aconitase 2, mitochondrial" (ACO2)[1][3][4]. - If you meant to refer to the active enzyme, use "Aconitase 2, mitochondrial" or its abbreviation "ACO2". **Summary:** ACO2P2 is a non-coding pseudogene. It is not a receptor, enzyme, transporter, or recognized therapeutic target, and has no direct functional, disease, or drug interaction data in the literature. If you need data on the functional aconitase, refer instead to "Aconitase 2, mitochondrial" (ACO2).

Other names
ACO2P2Aconitase 2 pseudogene 2
02

Biological functions

Other (No known functional protein product; non-coding)
03

Disease associations

Other (Not directly implicated; pseudogenes generally do not have direct roles, though occasionally they may have regulatory effects)

Beyond the preview

Go deeper on Aconitase 2 pseudogene 2 (ACO2P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aconitase 2 pseudogene 2 (ACO2P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call